Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease
- 1 January 2014
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 443 (1) , 68-73
Abstract
No abstract availableKeywords
Funding Information
- National Basic Research Program of China (973 Program) (2010CB912104)
- National Natural Science Fund of China (81070235, 81173078, 30930025)
This publication has 38 references indexed in Scilit:
- IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in miceJournal of Clinical Investigation, 2012
- Alcoholic Liver Disease: Pathogenesis and New Therapeutic TargetsGastroenterology, 2011
- Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitisBMC Gastroenterology, 2011
- β-Catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in miceHepatology, 2011
- An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: Regulation of proinflammatory cytokines and hepatic steatosis in miceHepatology, 2010
- Activation of the Farnesoid X Receptor Provides Protection against Acetaminophen-Induced Hepatic ToxicityMolecular Endocrinology, 2010
- FXR Acetylation Is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease StatesCell Metabolism, 2009
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory responseHepatology, 2008
- Effect of chronic alcohol consumption on Hepatic SIRT1 and PGC-1α in ratsBiochemical and Biophysical Research Communications, 2008
- Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding modelJournal of Hepatology, 2006